Search Results - "Sanjay, Apoorva Bharthur"

Refine Results
  1. 1

    Characterization of gene expression patterns in mild cognitive impairment using a transcriptomics approach and neuroimaging endophenotypes by Bharthur Sanjay, Apoorva, Patania, Alice, Yan, Xiaoran, Svaldi, Diana, Duran, Tugce, Shah, Niraj, Nemes, Sara, Chen, Eric, Apostolova, Liana G.

    Published in Alzheimer's & dementia (01-12-2022)
    “…Introduction Identification of novel therapeutics and risk assessment in early stages of Alzheimer's disease (AD) is a crucial aspect of addressing this…”
    Get full text
    Journal Article
  2. 2

    Predicting the Emergence of Major Neurocognitive Disorder Within Three Months After a Stroke by Aamodt, Eva Birgitte, Schellhorn, Till, Stage, Edwin, Sanjay, Apoorva Bharthur, Logan, Paige E., Svaldi, Diana Otero, Apostolova, Liana G., Saltvedt, Ingvild, Beyer, Mona Kristiansen

    Published in Frontiers in aging neuroscience (16-08-2021)
    “…Background: Neurocognitive disorder (NCD) is common after stroke, with major NCD appearing in about 10% of survivors of a first-ever stroke. We aimed to…”
    Get full text
    Journal Article
  3. 3

    Effect of genetic and vascular AD risk factors on rate of cognitive decline in EOAD vs LOAD by Sanjay, Apoorva Bharthur, Li, Yunyi, Gao, Sujuan, Apostolova, Liana G.

    Published in Alzheimer's & dementia (01-12-2021)
    “…Background APOE ε4 and vascular factors are well‐known risk factors for developing AD. The effect of these risk factors on rate of cognitive decline in early‐…”
    Get full text
    Journal Article
  4. 4

    Sexually dimorphic association of circulating leptin levels with early amyloid‐beta pathology assessed by amyloid PET by Ishii, Makoto, Iadecola, Costantino, Sanjay, Apoorva Bharthur, Apostolova, Liana G.

    Published in Alzheimer's & dementia (01-12-2021)
    “…Background Weight loss can precede the cognitive decline in Alzheimer’s Disease (AD), suggesting that mechanisms regulating body weight such as the adipocyte…”
    Get full text
    Journal Article
  5. 5

    Gene co‐expression network analyses in Mild cognitive impairment by Dorsant‐Ardon, Valerie, Sanjay, Apoorva Bharthur, Rocha, Luis M, Correia, Rion Brattig, Apostolova, Liana G.

    Published in Alzheimer's & dementia (01-12-2023)
    “…Background Multiomic data analysis has been extensively developed in recent years. Particularly, microarray data can be used as biomarkers of disease of…”
    Get full text
    Journal Article
  6. 6

    Alzheimer’s Disease mechanistic pathways were discovered through in silico experiments in causal AI based digital twins by Sanjay, Apoorva Bharthur, Shokeen, Deepanshi, Shen, Xinyu, Shin, So‐Youn, Latourelle, Jeanne

    Published in Alzheimer's & dementia (01-12-2023)
    “…Background Beyond a single‐gene‐based approach, pathway‐based approaches have become important in drug development paradigm. Several pathways are known for the…”
    Get full text
    Journal Article
  7. 7

    Gene co‐expression network analyses in Mild cognitive impairment by Dorsant‐Ardon, Valerie, Sanjay, Apoorva Bharthur, Rocha, Luis M, Correia, Rion Brattig, Apostolova, Liana G.

    Published in Alzheimer's & dementia (01-12-2023)
    “…Background Multiomic data analysis has been extensively developed in recent years. Particularly, microarray data can be used as biomarkers of disease of…”
    Get full text
    Journal Article
  8. 8

    Transcriptomic profiling of brain amyloidosis using peripheral blood‐based gene expression: Biomarkers (non‐neuroimaging) / plasma/serum/urine biomarkers by Sanjay, Apoorva Bharthur, Svaldi, Diana Otero, Apostolova, Liana G.

    Published in Alzheimer's & dementia (01-12-2020)
    “…Abstract Background In an effort towards pre‐symptomatic risk assessment, precision medicine and biomarker development in AD, we evaluated the efficacy of…”
    Get full text
    Journal Article
  9. 9

    Transcriptomic profiling of brain amyloidosis using peripheral blood‐based gene expression by Sanjay, Apoorva Bharthur, Svaldi, Diana Otero, Apostolova, Liana G.

    Published in Alzheimer's & dementia (01-12-2020)
    “…Background In an effort towards pre‐symptomatic risk assessment, precision medicine and biomarker development in AD, we evaluated the efficacy of…”
    Get full text
    Journal Article
  10. 10

    Chromosome 19 polygenic risk scores defined by deep learning model predict the rate of Alzheimer’ disease progression by Bae, Jinhyeong, Sanjay, Apoorva Bharthur, Nho, Kwangsik, Saykin, Andrew J., Penchev, Valentin, Apostolova, Liana G.

    Published in Alzheimer's & dementia (01-06-2023)
    “…Background Genetic variants invariably play a crucial role in rate of disease progression. The effects of Alzheimer’s disease (AD) genetic risk factors on…”
    Get full text
    Journal Article
  11. 11

    Transcriptomic profiling of brain amyloidosis and Alzheimer’s disease phenotypes identifies novel gene targets from peripheral blood gene expression data by Sanjay, Apoorva Bharthur, Svaldi, Diana, Logan, Paige E., Stage, Eddie, Apostolova, Liana G.

    Published in Alzheimer's & dementia (01-06-2023)
    “…Background In an effort towards pre‐symptomatic risk assessment, precision medicine and biomarker development in AD, we evaluated the efficacy of…”
    Get full text
    Journal Article
  12. 12

    Transcriptomic profiling in mild cognitive impairment using peripheral blood gene co‐expression networks by Sanjay, Apoorva Bharthur, Correia, Rion Brattig, Rocha, Luis M., Apostolova, Liana G.

    Published in Alzheimer's & dementia (01-12-2021)
    “…Background In an effort towards AD prodromal risk assessment, precision medicine and biomarker development, we evaluated the efficacy of characterizing and…”
    Get full text
    Journal Article
  13. 13

    Characterization of genetic expression patterns in MCI using a multiomics approach and neuroimaging endophenotypes by Sanjay, Apoorva Bharthur, Patania, Alice, Yan, Xiaoran, Svaldi, Diana, Apostolova, Liana G.

    Published in Alzheimer's & dementia (01-12-2020)
    “…Background Our goal was to characterize gene expression patterns at the MCI stage using a multiomics approach involving the integration of neuroimaging MRI…”
    Get full text
    Journal Article
  14. 14

    Characterization of genetic expression patterns in MCI using a multiomics approach and neuroimaging endophenotypes: Biomarkers (non‐neuroimaging): EEG and other biomarkers by Sanjay, Apoorva Bharthur, Patania, Alice, Yan, Xiaoran, Svaldi, Diana, Apostolova, Liana G.

    Published in Alzheimer's & dementia (01-12-2020)
    “…Abstract Background Our goal was to characterize gene expression patterns at the MCI stage using a multiomics approach involving the integration of…”
    Get full text
    Journal Article
  15. 15

    APOE ε4 carrier status and sex differentiate rates of cognitive decline in early‐ and late‐onset Alzheimer's disease by Polsinelli, Angelina J., Logan, Paige E., Lane, Kathleen A., Manchella, Mohit K., Nemes, Sára, Sanjay, Apoorva Bharthur, Gao, Sujuan, Apostolova, Liana G.

    Published in Alzheimer's & dementia (01-05-2023)
    “…Background We studied the effect of apolipoprotein E (APOE) ε4 status and sex on rates of cognitive decline in early‐ (EO) and late‐ (LO) onset Alzheimer's…”
    Get full text
    Journal Article
  16. 16

    Early‐onset APOE‐ε4 carriers show greater decline in memory, language and executive function than late‐onset carriers by Logan, Paige E., Lane, Kathleen A., Manchella, Mohit K., Sanjay, Apoorva Bharthur, Gao, Sujuan, Apostolova, Liana G.

    Published in Alzheimer's & dementia (01-12-2021)
    “…Background Apolipoprotein‐ε4 (APOE‐ε4) is the strongest genetic risk factor for sporadic Alzheimer’s disease (AD). However, whether APOE‐ε4 accelerates…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20